Citations

Citations to this article as recorded by  

• Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
  S. Afsar, Rahamat Unissa Syed, Weam M. A. Khojali, Najat Masood, Mhdia Elhadi Osman, J. Siva Jyothi, Mohd. Abdul Hadi, Amna Abakar Suleiman Khalifa, Nayla Ahmed Mohammed Aboshouk, Hessa Ahmed Alsaikhan, Aljuri Saleh Alafnan, Bushra Abdullah Alrashidi
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(1): 297.     CrossRef
• The role of non-coding RNAs in the regulation of cell death pathways in melanoma
  Yekta Metanat, Maria Sviridova, Bareq N. Al-Nuaimi, Fateme Janbazi, Mahtab Jalali, Nogol Ghalamkarpour, Elnaz Khodabandehloo, Ehsan Ahmadi
  Discover Oncology.2025;[Epub]     CrossRef
• Establishment of Initiated Cell Line Derived From NIH3T3 Fibroblasts
  Myeong‐Han Ro, Taehyun Park, SungHee Hwang, Hye‐Gyo Kim, Michael Lee, Misu Lee
  IUBMB Life.2025;[Epub]     CrossRef
• Tumor microenvironment responded naturally extracted FOF1-ATPase loaded chromatophores for antitumor therapy
  Weiyong Hong, Bang Lou, Ying Gao, Hui Zhao, Sanjun Ying, Saicheng Yang, Hanbing Li, Qingliang Yang, Gensheng Yang
  International Journal of Biological Macromolecules.2023; 230: 123127.     CrossRef
• MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation
  Elizabeth Proaño-Pérez, Laia Ollé, Yanru Guo, Cristina Aparicio, Mario Guerrero, Rosa Muñoz-Cano, Margarita Martin
  International Journal of Molecular Sciences.2023; 24(4): 3515.     CrossRef
• Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
  Elisabetta Fratta, Giorgio Giurato, Roberto Guerrieri, Francesca Colizzi, Jessica Dal Col, Alessandro Weisz, Agostino Steffan, Barbara Montico
  Cell Death Discovery.2023;[Epub]     CrossRef
• BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
  Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, Stefania Rossi, Maria Elena Pisanu, Maria Bellenghi, Carla Lintas, Claudio Tabolacci
  Cancers.2023; 15(16): 4026.     CrossRef
• METTL3 promotes Non-Small-Cell Lung Cancer Growth and Metastasis by Inhibiting FDX1 Through Copper Death-Associated Pri-miR-21-5p Maturation
  Shuai Qian, Jun Liu, Wenliang Liao, Fengping Wang
  Epigenomics.2023; 15(23): 1237.     CrossRef
• A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
  Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri, Mohammad Samadian
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy
  Lauretta Levati, Cristian Bassi, Simona Mastroeni, Laura Lupini, Gian Carlo Antonini Cappellini, Laura Bonmassar, Ester Alvino, Simona Caporali, Pedro Miguel Lacal, Maria Grazia Narducci, Ivan Molineris, Federica De Galitiis, Massimo Negrini, Giandomenico
  Cancers.2022; 14(15): 3706.     CrossRef
• Paradoxical downregulation of LPAR3 exerts tumor-promoting activity through autophagy induction in Ras-transformed cells
  Sung-Hee Hwang, Hye-Gyo Kim, Michael Lee
  BMC Cancer.2022;[Epub]     CrossRef
• SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microphthalmia-Associated Transcription Factor, Decreasing the Proliferation of Gastrointestinal Stromal Tumors
  Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Cindy Mancia, Arnau Navinés-Ferrer, Mario Guerrero, Margarita Martin
  Cancers.2022; 14(24): 6198.     CrossRef
• Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells
  Min Seung Lee, So Hyun Lim, Ah-Ran Yu, Chi Yeon Hwang, Insug Kang, Eui-Ju Yeo
  Biology.2021; 10(2): 153.     CrossRef
• Resistance to Molecularly Targeted Therapies in Melanoma
  Meet Patel, Adam Eckburg, Shahina Gantiwala, Zachary Hart, Joshua Dein, Katie Lam, Neelu Puri
  Cancers.2021; 13(5): 1115.     CrossRef
• Learning from Embryogenesis—A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development
  Lisa Linck-Paulus, Lisa Lämmerhirt, Daniel Völler, Katharina Meyer, Julia C. Engelmann, Rainer Spang, Norbert Eichner, Gunter Meister, Silke Kuphal, Anja Katrin Bosserhoff
  Journal of Clinical Medicine.2021; 10(11): 2259.     CrossRef
• METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246
  Xuehan Bi, Xiao Lv, Dajiang Liu, Hongtao Guo, Guang Yao, Lijuan Wang, Xiaolei Liang, Yongxiu Yang
  Cell Death Discovery.2021;[Epub]     CrossRef
• Choosing The Right Animal Model for Renal Cancer Research
  Paweł Sobczuk, Anna Brodziak, Mohammed Imran Khan, Stuti Chhabra, Michał Fiedorowicz, Marlena Wełniak-Kamińska, Kamil Synoradzki, Ewa Bartnik, Agnieszka Cudnoch-Jędrzejewska, Anna M. Czarnecka
  Translational Oncology.2020; 13(3): 100745.     CrossRef
• Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma
  Sara Carpi, Beatrice Polini, Stefano Fogli, Adriano Podestà, Erkko Ylösmäki, Vincenzo Cerullo, Antonella Romanini, Paola Nieri
  Expert Review of Molecular Diagnostics.2020; 20(1): 19.     CrossRef
• Autophagy inhibition in 3T3-L1 adipocytes breaks the crosstalk with tumor cells by suppression of adipokine production
  Sung-Hee Hwang, Michael Lee
  Animal Cells and Systems.2020; 24(1): 17.     CrossRef
• Roles of S100 family members in drug resistance in tumors: Status and prospects
  Xin Hua, Hongming Zhang, Jinfang Jia, Shanshan Chen, Yue Sun, Xiaoli Zhu
  Biomedicine & Pharmacotherapy.2020; 127: 110156.     CrossRef
• MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
  Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Paolo Antonio Ascierto, Maria Vincenza Carriero
  International Journal of Molecular Sciences.2020; 21(12): 4544.     CrossRef
• Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains
  Loredana Guglielmi, Marta Nardella, Carla Musa, Ingrid Cifola, Manuela Porru, Beatrice Cardinali, Ilaria Iannetti, Chiara Di Pietro, Giulia Bolasco, Valentina Palmieri, Laura Vilardo, Nicolò Panini, Fabrizio Bonaventura, Massimiliano Papi, Ferdinando Scav
  Cancers.2020; 12(6): 1635.     CrossRef
• MiR‐1246 promotes anti‐apoptotic effect of mini‐αA in oxidative stress‐induced apoptosis in retinal pigment epithelial cells
  Qianyin Chen, Huimin Lin, Xuan Deng, Shengnan Li, Jinglin Zhang
  Clinical & Experimental Ophthalmology.2020; 48(5): 682.     CrossRef
• Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
  Ilaria Proietti, Nevena Skroza, Nicoletta Bernardini, Ersilia Tolino, Veronica Balduzzi, Anna Marchesiello, Simone Michelini, Salvatore Volpe, Alessandra Mambrin, Giorgio Mangino, Giovanna Romeo, Patrizia Maddalena, Catherine Rees, Concetta Potenza
  Cancers.2020; 12(10): 2801.     CrossRef
• The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma
  Luigi Fattore, Rita Mancini, Paolo Antonio Ascierto, Gennaro Ciliberto
  Expert Opinion on Therapeutic Targets.2019; 23(1): 53.     CrossRef
• A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response
  Ryan K. van Laar, Mitchel T. Lincoln, Barton J. van Laar
  Melanoma Research.2019; 29(1): 19.     CrossRef
• A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients
  Zhiyan Wang, Jinru Lv, Xuan Zou, Zebo Huang, Huo Zhang, Qingxie Liu, Lin Jiang, Xin Zhou, Wei Zhu
  Gene.2019; 693: 37.     CrossRef
• The origin of exosomal miR-1246 in human cancer cells
  Yi-Fan Xu, Bethany N. Hannafon, Ujjwol Khatri, Amy Gin, Wei-Qun Ding
  RNA Biology.2019; 16(6): 770.     CrossRef
• Differential Gene Expression Common to Acquired and Intrinsic Resistance to BRAF Inhibitor Revealed by RNA-Seq Analysis
  Jun-Ho Ahn, Sung-Hee Hwang, Hyun-Soo Cho, Michael Lee
  Biomolecules & Therapeutics.2019; 27(3): 302.     CrossRef
• MicroRNA heterogeneity in melanoma progression
  Anita Thyagarajan, Kenneth Y. Tsai, Ravi P. Sahu
  Seminars in Cancer Biology.2019; 59: 208.     CrossRef
• miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
  Simona Caporali, Adriana Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar, Gian Carlo Antonini Cappellini, Nadia Felli, Alessandra Carè, Ulrich Pfeffer, Stefania D’Atri
  Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
• MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53
  Ran Xu, Huabing Li, Shuiqing Wu, Jian Qu, Haiyan Yuan, Yangang Zhou, Qiong Lu
  International Urology and Nephrology.2019; 51(10): 1771.     CrossRef
• The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers
  Douglas Donnelly, Phyu P. Aung, George Jour
  Seminars in Cancer Biology.2019; 59: 165.     CrossRef
• Upregulation of S100A9 contributes to the acquired resistance to BRAF inhibitors
  Sung-Hee Hwang, Jun-Ho Ahn, Michael Lee
  Genes & Genomics.2019; 41(11): 1273.     CrossRef
• Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway
  Shaimaa A. Gad, Hamdy E. A. Ali, Rofaida Gaballa, Rania M. Abdelsalam, Mourad Zerfaoui, Hamed I. Ali, Salwa H. Salama, Sanaa A. Kenawy, Emad Kandil, Zakaria Y. Abd Elmageed
  Scientific Reports.2019;[Epub]     CrossRef
• The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
  Xiao Liu, Jinfeng Wu, Haihong Qin, Jinhua Xu
  Targeted Oncology.2018; 13(4): 437.     CrossRef
• Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor
  Xiaohui Wang, Huajun Qu, Yinghe Dong, Guozhi Wang, Yuchen Zhen, Linxia Zhang
  Cancer Biomarkers.2018; 23(1): 67.     CrossRef
• Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4
  Li-Jun Mo, Man Song, Qiao-Hua Huang, Hua Guan, Xiao-Dan Liu, Da-Fei Xie, Bo Huang, Rui-Xue Huang, Ping-Kun Zhou
  British Journal of Cancer.2018; 119(4): 492.     CrossRef
• An oasis in the desert of cancer chemotherapeutic resistance: The enlightenment from reciprocal crosstalk between signaling pathways of UPR and autophagy in cancers
  Yuhang Zhang, Xianjun Qu, Lingfan Jiang
  Biomedicine & Pharmacotherapy.2017; 92: 972.     CrossRef

Citations

Citations to this article as recorded by  

• Research advancements and evaluation of multifactor‐induced murine models for gastric cancer
  Yiqing Wang, Liang Zhang, Weixu Feng, Wanfeng Liu, Xiangyang Xue, Shiyu Feng
  Animal Models and Experimental Medicine.2025;[Epub]     CrossRef
• The Mechanism of miR-222 Targets Matrix Metalloproteinase 1 in Regulating Fibroblast Proliferation in Hypertrophic Scars
  Yi Zhang, Wei-Long Hong, Zhi-Ming Li, Qi-Yu Zhang, Kang Zeng
  Aesthetic Plastic Surgery.2021; 45(2): 749.     CrossRef
• Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer
  Shinichi Umeda, Mitsuro Kanda, Takashi Miwa, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera
  International Journal of Cancer.2020; 146(10): 2865.     CrossRef
• Aldehyde dehydrogenase 1, a target of miR‑222, is expressed at elevated levels in cervical cancer
  Changde Liu, Yan Zhang, Shanghua Liang, Yuhua Ying
  Experimental and Therapeutic Medicine.2020;[Epub]     CrossRef
• Expression and regulatory role of miRNA-222 in intervertebral disc degeneration (IDD)
  Chen Ge, Changwei Li
  Biotechnology & Biotechnological Equipment.2019; 33(1): 1553.     CrossRef
• MicroRNA-222 regulates the viability of fibroblasts in hypertrophic scars via matrix metalloproteinase 1
  Yi Zhang, Xiaohua Lin, Li Zhang, Weilong Hong, Kang Zeng
  Experimental and Therapeutic Medicine.2017;[Epub]     CrossRef